HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19
HLA · 2023-12 · 102 (6) · 731-739
DOI: 10.1111/tan.15160 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2023-08. Verfasst von Patricia Castro-Santos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Pública Galega de Medicina Xenómica (SERGAS), Centro Nacional de Genotipado, Health Research Institute of Santiago de Compostela (IDIS), Sa…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, European Regional Development Fund.
Abstract (Originalsprache)
We analyzed the association between HLA polymorphisms and susceptibility to SARS‐CoV‐2 infection and disease severity. Genotyping data from a total of 9373 COVID‐19‐positive cases from the Spanish Coalition to Unlock Research on Host Genetics on COVID‐19 (SCOURGE) consortium and 5943 population controls were included in the study. We found an association of the alleles HLA‐B*14:02 and HLA‐C*08:02 with a lower risk to COVID‐19 infection ( p = 0.006, OR = 0.84, 95% CI = [0.75–0.95], p = 0.024, OR = 0.86, 95% CI = [0.78–0.95], respectively). We also found the alleles HLA‐A*11:01 and HLA‐C*04:01 associated with disease severity ( p = 0.033, OR = 1.16, 95% CI = [1.04–1.31], p = 0.045, OR = 1.14, 95% CI = [1.05–1.25], respectively). These results suggest that an effective presentation of viral peptides by HLA class I alleles involve a faster infection clearance, decreasing the susceptibility and severity of COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fundación Pública Galega de Medicina Xenómica (SERGAS), Centro Nacional de Genotipado, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
- Faculty of Health Sciences, Universidad Autónoma de Chile, Talca, Chile.
- Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico.
- IDIVAL, Cantabria, Spain.
- Universidad de Cantabria, Cantabria, Spain.
- Hospital U M Valdecilla, Cantabria, Spain.
ORCID-Profile: Roberto Díaz-Peña
Förderung
- Instituto de Salud Carlos III
- European Regional Development Fund
Zitieren
APA
Castro-Santos, P., Rojas-Martinez, A., Riancho, J. A., Lapunzina, P., Flores, C., Carracedo, Á., Díaz-Peña, R., & Scourge Cohort Group (2023). HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19. HLA, 102(6), 731-739. https://doi.org/10.1111/tan.15160
Vancouver
Castro-Santos P, Rojas-Martinez A, Riancho JA, Lapunzina P, Flores C, Carracedo Á, et al. HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19. HLA. 2023;102(6):731-739. doi:10.1111/tan.15160
BibTeX
@article{CastroSantos2023,
author = {Castro-Santos, Patricia and Rojas-Martinez, Augusto and Riancho, José A and Lapunzina, Pablo and Flores, Carlos and Carracedo, Ángel and Díaz-Peña, Roberto and Scourge Cohort Group, Scourge Cohort Group},
title = {HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19},
journal = {HLA},
year = {2023},
volume = {102},
number = {6},
pages = {731--739},
doi = {10.1111/tan.15160}
}
EUVIMED